Tradestie Institutional Equity Comparison Engine
CAPR vs IKT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CAPR Overall Edge
CAPR Captures Institutional Edge (3โ0 Pillars ยท 5โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Capricor Therapeutics Inc (CAPR) driven by superior Valuation, Momentum & Technical, Options & Structure. Fundamentally, CAPR trades at 78.7x Forward P/E with 0.0% operating margin (-7.9% YoY revenue) versus IKT at N/M Forward P/E and 0.0% operating margin (-100.0% YoY). In options structure, CAPR sits in CONSOLIDATION (89th %ile IV; Dealer Gamma Walls on Pro) against IKT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
CAPR
CAPR 78.7x vs IKT N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin 0.0% vs 0.0% ยท YoY -7.9% vs -100.0%
Momentum & Technical Winner
CAPR
1Y +44.3% vs -7.8% ยท 52W Pos 15% vs 6%
Options & Structure Winner
CAPR
CONSOLIDATION (89th %ile IV) vs UNCLASSIFIED (N/A IV)
CAPR
NASDAQ
Capricor Therapeutics Inc
Pharmaceutical Preparations
$8.47
-11.12% 1D
Market Cap
$595.4M
1M Return
+26.23%
1Y Return
+44.29%
Forward P/E
78.7x
Unified AI Score
28.0 / 100
SELL
Tech 50.0
Fund 37.0
Flow 68.0
Mom 50.0
IKT
NASDAQ
Inhibikase Therapeutics, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$1.48
-2.96% 1D
Market Cap
$214.6M
1M Return
-10.61%
1Y Return
-7.81%
Forward P/E
N/M
Unified AI Score
48.0 / 100
HOLD
Tech 57.0
Fund 52.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
CAPR +44.29%
IKT -7.81%
Spread: +54.6 pp (CAPR Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CAPR Revenue | IKT Revenue | CAPR Op. Margin | IKT Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2017 | $0M | N/A | -482.4% | N/A | CAPR |
| FY2018 | $0M | N/A | -917.0% | N/A | CAPR |
| FY2019 | $0M | N/A | -769.5% | N/A | CAPR |
| FY2020 | $0M | $0M | -4412.6% | -403.5% | IKT |
| FY2021 | $0M | $0M | -8549.9% | -476.2% | IKT |
| FY2022 | $0M | $0M | -1163.9% | -14686.2% | CAPR |
| FY2023 | $30M | $0M | -95.6% | -7712.0% | CAPR |
| FY2024 | $20M | N/A | -191.1% | N/A | CAPR |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CAPR | IKT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $595.4M | $214.6M | Larger Scale | CAPR |
| Trailing P/E Ratio Valuation | 78.7x | N/M | Lower Multiple | CAPR |
| Forward P/E Ratio Valuation | 78.7x | N/M | Lower Multiple | CAPR |
| Revenue Growth (YoY) Growth | -7.9% | -100.0% | Higher Growth | CAPR |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -100.5% | -52.9% | Higher ROE | IKT |
| 52-Week Range Position Momentum | 15% ($3โ$40) | 6% ($1โ$3) | Stronger Trend | CAPR |
| Beta / 30D Volatility Risk Regime | 1.52ฮฒ ยท 152% Vol | 1.62ฮฒ ยท 82% Vol | Lower Realized Risk | IKT |
| Unified Institutional Score Composite Signal | 28.0 / 100 (SELL) | 48.0 / 100 (HOLD) | Higher Composite | IKT |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full CAPR vs IKT Buy Guide
CAPR
CONSOLIDATION
56d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
89th %ile
IV Regime
Extreme (>80th %ile)
IKT
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither CAPR nor IKT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.